541096 Stock Overview
Bharat Parenterals Limited researches, develops, manufactures, markets, sources, and distributes pharmaceutical products in India.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Bharat Parenterals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,700.55 |
| 52 Week High | ₹1,701.80 |
| 52 Week Low | ₹321.20 |
| Beta | 0.90 |
| 1 Month Change | 52.27% |
| 3 Month Change | 110.48% |
| 1 Year Change | 417.99% |
| 3 Year Change | 322.50% |
| 5 Year Change | 818.72% |
| Change since IPO | 965.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| 541096 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 28.5% | 1.4% | 2.8% |
| 1Y | 418.0% | 57.2% | 46.6% |
Return vs Industry: 541096 exceeded the Indian Pharmaceuticals industry which returned 55.9% over the past year.
Return vs Market: 541096 exceeded the Indian Market which returned 46.4% over the past year.
Price Volatility
| 541096 volatility | |
|---|---|
| 541096 Average Weekly Movement | 10.5% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 541096's share price has been volatile over the past 3 months.
Volatility Over Time: 541096's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 377 | Bharatkumar Desai | bplindia.in |
Bharat Parenterals Limited researches, develops, manufactures, markets, sources, and distributes pharmaceutical products in India. The company provides products in the areas of anti-retroviral, antiprotozoal/anthelmintic, respiratory, antiallergic/anti-histaminic/anticold, cleansing agents/skin infections, antibiotics, cardiovascular systems, anti-diabetic, anti-tuberculosis, anti-fungal, antimalarial, gastrointestinal tract/alimentary systems, anti-inflammatory/anti-pyretic/analgesics, supplements, central nervous system, anaesthetics, anti-viral, steroids and hormones, uterine stimulant, anticancer, and others. It also provides general products, ß-lactum /cephalosporin products, and formulations.
Bharat Parenterals Limited Fundamentals Summary
| 541096 fundamental statistics | |
|---|---|
| Market cap | ₹9.90b |
| Earnings (TTM) | ₹252.07m |
| Revenue (TTM) | ₹2.42b |
39.3x
P/E Ratio4.1x
P/S RatioIs 541096 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 541096 income statement (TTM) | |
|---|---|
| Revenue | ₹2.42b |
| Cost of Revenue | ₹1.46b |
| Gross Profit | ₹958.60m |
| Other Expenses | ₹706.53m |
| Earnings | ₹252.07m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 43.31 |
| Gross Margin | 39.64% |
| Net Profit Margin | 10.42% |
| Debt/Equity Ratio | 43.2% |
How did 541096 perform over the long term?
See historical performance and comparison